Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
75,462,362
-
Total 13F shares
-
10,546,110
-
Share change
-
-736,158
-
Total reported value
-
$13,710,730
-
Put/Call ratio
-
0%
-
Price per share
-
$1.30
-
Number of holders
-
36
-
Value change
-
-$1,206,472
-
Number of buys
-
6
-
Number of sells
-
26
Institutional Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q2 2022
As of 30 Jun 2022,
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,546,110 shares.
The largest 10 holders included
Sofinnova Investments, Inc., Novo Holdings A/S, Blackstone Inc., Tekla Capital Management LLC, Nan Fung Group Holdings Ltd, VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Ensign Peak Advisors, Inc.
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.